More than 50% of Valenta Medicines Are Included into ENL 2016

On March 1, the Essential Medicines List (EML) for medical application in 2016 approved in last December (the Order of the Government of the Russian Federation 2724-r, dated December 26, 2015) entered into force. More than 50% of Valenta medicines were included in EML for this year.

Marat Sakaev, PR & GA Director, JSC «Valenta Pharm»: «Currently, Valenta portfolio includes more than 90 medical products. Despite the complicated economic situation prevailing in the country, our priority is to provide affordable and high-quality medicines to patients and medical organizations for prices set by the government».